Navigation Links
Verde Environmental Technologies Wins National Contract from NIDA/NIH for Development of Home Drug Deactivation System

MINNEAPOLIS, Sept. 17, 2013 /PRNewswire/ -- Verde Environmental Technologies of Burnsville, MN has been awarded a Phase 1 SBIR (Small Business Innovation Research) contract by the National Institute on Drug Abuse (NIDA), a branch of the National Institutes of Health (NIH) for the development of an inexpensive at home deactivation system for unwanted abusable psychoactive drugs. The contract (NIDA Ref. N43DA-13-4420) specifies the development of a system that would provide a simple way to safely inactivate and contain unwanted prescription drugs, thereby minimizing the potential for diversion or accidental exposure, and providing a safe and environmentally responsible way to properly dispose of pharmaceuticals.

"This is an important step for our company and for the general public," said Andrew Korey, PhD, Verde's CEO. "We believe that our at-source deactivation strategy for unused drugs will help combat the growing problems of abuse or diversion of drugs from the home," he added. Verde will develop a new product design in their Medsaway® 'single prescription' size format for disposal of unwanted controlled psychoactive prescriptions in pill, liquid, or transdermal dosage forms. As part of the contract, Verde will also conduct user testing, toxicity, and risk assessment evaluations.

The development of a new single prescription size of Medsaway could also expand the company's product offerings in pharmacies and could possibly be co-dispensed with prescriptions.

Disposal of unwanted pharmaceuticals has become a significant problem, causing environmental contamination of groundwater, as well as the significant risk of abuse or misuse of medications from the home. While community take back programs have been successful in accumulating tons of unwanted medications, such programs are expensive, take place infrequently, are inconvenient, and have been shown to only succeed in addressing a minor percentage of total unused drug accumulation. Verde has developed products that allow unwanted medication to be rendered safely inactivated and disposed of in an environmentally acceptable manner. Verde's proprietary Medsorb™ technology uses activated carbon, which is highly effective in adsorbing and firmly binding pharmaceuticals, rendering them inactive, and unrecoverable, and providing for an environmentally sound disposal method.

About Verde:
Verde is a privately held innovative organization, with manufacturing and operations based in Minnesota. Verde products include Medsaway systems (SP, Home, Professional, and XL) and Medsaway ContraPatch™ for safe inactivation of transdermal patches. More information about our products can be found at and


SOURCE Verde Environmental Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma er stolt over at bakke op om HAE-dag :-) 2013 og vi hjælper HAE-patienter med at fylde verden med smil
2. Varian Medical Systems Publishes 2013 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
3. NASA Awards Environmental Engineering and Occupational Health Services Contract
4. MO BIO Laboratories, Inc. launches a new kit for isolation of viral nucleic acids from environmental samples
5. LodgeNet Healthcare, Siemens Partner To Deliver Bedside Environmental Controls For Maple Grove Hospital
6. B. Braun Joins National Health Organization Supporting Environmental Practices
7. Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
8. International Isotopes Inc. Announces Nuclear Regulatory Commission Approval Of The Final Environmental Impact Statement For The Planned Depleted Uranium De-Conversion And Fluorine Extraction Processing Facility
9. SpineMark Corporation Partners with PhDx and Millennium Environmental to Create an ISO type Spine Protocol Management System
10. Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty
11. PendoTECH Single Use Process Sensors Reduce The Environmental Impact Of Critical Bioprocess Operations
Post Your Comments:
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):